JetEquities

Moleculin Announces COVID-19 In Vivo Testing Contracted for WP11

Long
NASDAQ:MBRX   Moleculin Biotech, Inc.
MBRX: Moleculin Biotech, Inc.
2020-09-14 07:30:00
Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.